Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
Companies

Menarini Biotech S.r.l.

Menarini is an Italian pharmaceutical company that focuses mainly on cardiovascular, oncology, pain, inflammation and asthma.

The company in detail

Profile

Menarini Group is the largest Italian owned Pharmaceutical Group. The company has sales of over 2,4 billion euros and over 12,000 staff worldwide. The company spends over 122 million euros per annum on research and development in the following fields: cardiovascular, oncology, pain, inflammation and asthma.

The group has a range of compounds and biological entities in it's clinical pipeline, developed in-house or in-licensed. We currently have several biologic entities (Cardiovascular and Oncology) at late stage development (Phase 3) in our pipeline and we are interested in adding to this portfolio by in-licensing particularly in the previously mentioned therapeutic areas, primarily focussing on large molecules to enhance the portfolio.

Menarini Biotech is an integral part of the group and assists our licensing and R&D functions in the evaluation and selection of in-licensing opportunities. We are a centre of excellence for biotechnology in Italy.

We have our own development and manufacturing facilities for cell culture and microbial fermentation derived biologics and we can also provide services as CMO in cGMP biologics/biosimilars API purified bulks production for (non) clinical trials and in analytical methods development/therapeutic proteins characterization. We have international experts and an experienced team who have developed and commercialised many biologic products and look forward to successfully commercialising your product.

Partnering strategy/interests

Menarini has a deep-rooted history and a strategy of international agreements with other companies through the licensing of innovative products. Menarini Biotech also provides consultancy and contract development and manufacturing.

In-licensing

Large molecule, biologic products sought, particularly in the following therapeutic fields: cardiovascular disease, oncology, pain, inflammation and asthma. More

R&D

To view this information, you must subscribe to Partneringtools.

Partnerships

To view this information, you must subscribe to Partneringtools.

Head office

Menarini Biotech S.r.l.
Via Tito Speri, 12
Pomezia/Rome
00040
Italy

Tel:  (39) 0691 184491
Fax: (39) 0691 601408
www | email

Contact details

Dr. Andrew Slade
ManagingDirector Menarini Biotech
Business Development
Request more information

Company figures

Formed: 1986
Annual Turnover: €>2,4billion (2005)
Number of employees: 56

Related categories

Partnering consultation free of charge
Therapeutic Area Partnerships
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us